SRI-11226

N/A

Report date: 2025/01/26 19:04:04
NME

Base Information

Drug NameSRI-11226
Drug Alias Namedual 5- and 12-LOX inhibitor (SRI International)SRI-11226
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action12-lipoxygenase inhibitorsArachidonate 5-lipoxygenase inhibitors
Targets12-lipoxygenaseArachidonate 5-lipoxygenase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSri International
China Registration ClassN/A

Develop Information

Active CompaniesSri International
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A